Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: don roberson who wrote (2497)	11/14/1997 1:45:00 PM
From: Vol	Read Replies (1) \| Respond to of 23519

25 is like an iron ceiling to VVUS - it just keeps bouncing off!

To: don roberson who wrote (2497)	11/14/1997 1:55:00 PM
From: Mark A. Stang	Respond to of 23519

Who said anything about "after"? Maybe Pfizer will give away free coupons for Caopectate with every Viagra prescription. >>Oh, thats going to be nice, after love making!!!!!!!!!!!!!!!!<<

To: don roberson who wrote (2497)	11/14/1997 3:21:00 PM
From: Sidney Merle Foster	Respond to of 23519

Don, After lovemaking? What about during lovemaking. Talk about a gross turnoff. Sid

To: don roberson who wrote (2497)	11/14/1997 4:23:00 PM
From: BigKNY3	Read Replies (3) \| Respond to of 23519

It's June, 1998, you are a primary care physician (and non-VVUS shareholder)..You have been seeing a particular older patient for years but he tells you for the first time that he has an ED problem...You have the option of prescribing MUSE or a newly approved oral agent that is priced at a substantial discount to MUSE. Which product will the physician find easier to discuss and prescribe to this patient? What will be the potential greater fear for the patient; the fear of diarrhea, the fear of long-term side effects or the fear of placing a pellet into the penis? BigKNY3